Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30 results about "Haemophilus paragallinarum" patented technology

Preparation method of chicken infectious rhinitis and mycoplasma gallisepticum bivalent lipid inactivated vaccine

The invention provides a preparation method of a chicken infectious rhinitis and mycoplasma gallisepticum bivalent lipid inactivated vaccine, belonging to the technical field of biological products for animals. The preparation method is implemented by the following steps of: preparing a type A haemophilus paragallinarum inactivated antigen bacterial liquid, a type C haemophilus paragallinarum inactivated antigen bacterial liquid and a mycoplasma gallisepticum antigen liquid; uniformly mixing the type A haemophilus paragallinarum inactivated antigen bacterial liquid with the type C haemophilus paragallinarum inactivated antigen bacterial liquid in the volume ratio of 1:1 to obtain a mixed haemophilus paragallinarum inactivated antigen bacterial liquid; uniformly mixing the mixed haemophilus paragallinarum inactivated antigen bacterial liquid with the mycoplasma gallisepticum antigen liquid in the ratio of 1:1-1:1.5, pouring into an emulsifying tank and stirring; slowly adding poplar bark lipid till the final volume percentage concentration of the poplar bark lipid in the mixture is 2.0-3.8 percent; and continually stirring and emulsifying for 30-60 minutes. The vaccine has the advantages of easiness for absorbing, no toxic or side effect, short immunogenic time, long immune duration, good immune effect and capability of effectively preventing chicken infectious rhinitis and mycoplasma gallisepticum.
Owner:SHANDONG BINZHOU BOLAIWEI BIOTECH

Preparation method of chicken infectious rhinitis lipid inactivated vaccine

The invention provides a preparation method of a chicken infectious rhinitis lipid inactivated vaccine, belonging to the technical field of biological products for animals. The preparation method is implemented by the following steps of: preparing a type A haemophilus paragallinarum inactivated antigen bacterial liquid and a type C haemophilus paragallinarum inactivated antigen bacterial liquid; uniformly mixing the type A haemophilus paragallinarum inactivated antigen bacterial liquid with the type C haemophilus paragallinarum inactivated antigen bacterial liquid in the volume ratio of 1:1, and pouring into an emulsifying tank; stirring with a mixer; slowly adding poplar bark lipid at a low speed till the final volume percentage concentration of the poplar bark lipid in the mixture is 2.0-3.8 percent; and continually stirring and emulsifying for 30-60 minutes to obtain the vaccine, wherein the final bacterium content of a type A strain and the final bacterium content of a type C strain in the vaccine are 1,000,000,000 cfu/ml. The vaccine has the advantages of easiness for absorbing, no toxic or side effect, short immunogenic time, long immune duration, good immune effect and capability of effectively preventing chicken infectious rhinitis and mycoplasma gallisepticum.
Owner:SHANDONG BINZHOU BOLAIWEI BIOTECH

Haemophilus paragallinarum, inactivated vaccine and preparation method of inactivated vaccine

The invention discloses haemophilus paragallinarum, an activated vaccine, and a preparation method of the activated vaccine. The provided haemophilus paragallinarum is actually the HN-VA strain of haemophilus paragallinarum, and the HN-VA strain has been preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation address is No.1 West Beichen Road, Chaoyang District, Beijing, and the preservation number is CGMCC No.7211. For the first time, the HN-VA strain of haemophilus paragallinarum is adopted to prepare an activated vaccine for preventing chicken infectious rhinitis. The research and preparation of the inactivated vaccine effectively solve the problems that the chicken infectious rhinitis is hard to prevent, and the happening rate and death rate of the disease are high; moreover the inactivated vaccine will not generate any adverse reaction to chicken, the experimental safety is high, a high-titer neutralizing antibody will generate in the chicken after vaccination, and the immunity effect is good.
Owner:ZHENGZHOU HOUYI PHARMA

Haemophilus paragallinarum fluorogenic quantitative PCR detection method

InactiveCN105002284AEasy to operateNo further action requiredMicrobiological testing/measurementHaemophilusBiology
The invention discloses a haemophilus paragallinarum fluorogenic quantitative PCR detection method. According to the haemophilus paragallinarum fluorogenic quantitative PCR detection method, a hagA gene with the high degree of specificity and conservative property is selected as an amplification target gene, SYBR Green I fluorochrome is taken as a detection target, through the continuous optimization of fluorogenic quantitative PCR reaction conditions, the preparation of a standard substance and the establishment of a standard curve, the haemophilus paragallinarum fluorogenic quantitative PCR detection method of the SYBR Green I fluorochrome jogged with DNA, and the DNA of a haemophilus paragallinarum hagA genetic template can be quantified accurately. The haemophilus paragallinarum fluorogenic quantitative PCR detection method has the advantages of being strong in specificity, high in sensibility, simple in operation, rapid in detection, accurate in quantification and the like, the haemophilus paragallinarum fluorogenic quantitative PCR detection method can be used for clinic rapid diagnosis of haemophilus paragallinarum and the quantitative analysis of the degree of infection by the haemophilus paragallinarum, and the haemophilus paragallinarum fluorogenic quantitative PCR detection method is suitable for popularization and application.
Owner:SHANDONG BINZHOU ANIMAL SCI & VETERINARY MEDICINE ACADEMY

Preparation method of inactivated vaccine of infectious coryza of chicken

The invention discloses a preparation method of an inactivated vaccine of infectious coryza of chicken, which comprises the following steps: firstly, diluting haemophilus paragallinarum strains, inoculating a chicken agar plate, culturing at 37 DEG C for 22-24h; selecting a typical colony to inoculate a chicken agar slant culture-medium, culturing to obtain first class slant strains; secondly, getting the first class slant strains to inoculate into a chicken soup culture medium, vibrating and culturing at 37 DEG C for 12h, obtaining second class strains; thirdly, inoculating the second class strains into a semisynthetic culture medium, culturing by a biological fermentation cylinder; and inactivating to obtain the inactivated vaccine. Aiming at defects of complex process, high production cost, low yield and the like existing in the prior preparation method of the inactivated vaccine of infectious coryza of chicken, the research work of an improved production process is developed, and the important breakout on the culture method is obtained. The method has simple and feasible operation; compared with the prior art, the invention greatly improves the culture strains, shortens the culture time by 10-12h, and effectively lowers the production cost.
Owner:哈药集团生物疫苗有限公司

Haemophilus paragallinarum B strain fermentation medium, preparation method thereof and application thereof

The invention discloses a haemophilus paragallinarum B strain fermentation medium, a preparation method thereof and application thereof, and belongs to the field of agricultural microorganism. The haemophilus paragallinarum B strain fermentation medium is prepared from 5 to 100 g/L of casein peptone, 0.5 to 80 g/L of yeast powder, 0.5 to 80 g/L of polyvalent peptone, 0.5 to 20 g/L of sodium chloride, 0.5 to 20 g/L of sodium glutamate, 0.5 to 30 g/L of glucose, 0.5 to 30 g/L of fish meal peptone, 5 to 100 mL/L of chicken serum, 0.5 to 50 mL/L of microelement solution and 1 to 30 mL/L of NAD (Nicotinamide Adenine Dinucleotide) solution. The haemophilus paragallinarum B strain fermentation medium disclosed by the invention contains all nutritional ingredients which are needed for growth of haemophilus paragallinarum B strains, growth and metabolism of the strains are facilitated, the adaption period of thallus is shortened, the adaptive capacity of the thallus after inoculation is strong, the fermentation period is short, the viable bacteria quantity during harvesting is high, and the haemophilus paragallinarum B strain fermentation medium is suitable for large-scale application and has a wide prospect.
Owner:山东滨州沃华生物工程有限公司

Antigen analogue epi-peptide of para bacillus fowl blood phili and its use

InactiveCN1597693AEasy to operateGood economic benefits and market prospectsBacteria peptidesBiological testingSerotypePhenylalanine
An antigen mimicking epitope peptide of chicken parahemophilus has its amino acid sequence: CSWYFPX1X2C. It can be used to prepare the diagnosing reagent and vaccine of chicken's infectious rhinitis.
Owner:INST OF BASIC MEDICAL SCI ACAD OF MILITARY MEDICAL SCI OF PLA +1

Antigen simulating epipeptide of A type parachicken blood phili bacillus and its use

The invention relates to the antigen imitated epitope peptide of Haemophilus paragallinarum serovar A in China and its application, wherein its amino acid sequence is represented by the general formula of X1X2X3X4AX5DPVX6X7X8, wherein A represents alanine residue, D represents aspartate residue, P represents proline residue, V represents valine residue, X1-X8 represents any amino acids. The invention also discloses the use of the epitope peptide of Haemophilus paragallinarum serovar A -type in China as active ingredient in the preparation of vaccine for treating chicken infectious rhinitis.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES +1

Emodin methyl ether microemulsion and application thereof

The invention discloses an emodin methyl ether microemulsion and an application thereof. The emodin methyl ether microemulsion is a microemulsion system composed of an organic solvent and a surfactant. Preferably, the formula of the microemulsion system comprises one or more of N, N-dimethylformamide or N, N-dimethylacetamide, ethanol or Tween-20. In-vitro experiments prove that the physcion can be used for killing clinical drug-resistant bacillus cereus, enterococcus faecalis, bacillus gallisepticum, ornithobacterium rhinotracheitis, haemophilus paragallinarum, klebsiella, chlamydia psittaci, mycoplasma gallisepticum and mycoplasma synoviae. Meanwhile, animal experiments prove that the emodin methyl ether microemulsion is suitable for preventing and treating respiratory tract diseases caused by avian rhinotracheitis, haemophilus paragallinarum, klebsiella, chlamydia psittaci and mycoplasma gallisepticum clinically, liver rupture caused by bacillus cereus, enterococcus faecalis and chicken bacilli, and the like. The bovine mastitis and endometritis caused by klebsiella and bacillus cereus can be treated.
Owner:CHINA AGRI UNIV

Preparation method of inactivated vaccine of infectious coryza of chicken

The invention discloses a preparation method of an inactivated vaccine of infectious coryza of chicken, which comprises the following steps: firstly, diluting haemophilus paragallinarum strains, inoculating a chicken agar plate, culturing at 37 DEG C for 22-24h; selecting a typical colony to inoculate a chicken agar slant culture-medium, culturing to obtain first class slant strains; secondly, getting the first class slant strains to inoculate into a chicken soup culture medium, vibrating and culturing at 37 DEG C for 12h, obtaining second class strains; thirdly, inoculating the second class strains into a semisynthetic culture medium, culturing by a biological fermentation cylinder; and inactivating to obtain the inactivated vaccine. Aiming at defects of complex process, high production cost, low yield and the like existing in the prior preparation method of the inactivated vaccine of infectious coryza of chicken, the research work of an improved production process is developed, and the important breakout on the culture method is obtained. The method has simple and feasible operation; compared with the prior art, the invention greatly improves the culture strains, shortens the culture time by 10-12h, and effectively lowers the production cost.
Owner:哈药集团生物疫苗有限公司

Haemophilus paragallinarum type b strain fermentation medium, its preparation method and application

The invention discloses a haemophilus paragallinarum B strain fermentation medium, a preparation method thereof and application thereof, and belongs to the field of agricultural microorganism. The haemophilus paragallinarum B strain fermentation medium is prepared from 5 to 100 g / L of casein peptone, 0.5 to 80 g / L of yeast powder, 0.5 to 80 g / L of polyvalent peptone, 0.5 to 20 g / L of sodium chloride, 0.5 to 20 g / L of sodium glutamate, 0.5 to 30 g / L of glucose, 0.5 to 30 g / L of fish meal peptone, 5 to 100 mL / L of chicken serum, 0.5 to 50 mL / L of microelement solution and 1 to 30 mL / L of NAD (Nicotinamide Adenine Dinucleotide) solution. The haemophilus paragallinarum B strain fermentation medium disclosed by the invention contains all nutritional ingredients which are needed for growth of haemophilus paragallinarum B strains, growth and metabolism of the strains are facilitated, the adaption period of thallus is shortened, the adaptive capacity of the thallus after inoculation is strong, the fermentation period is short, the viable bacteria quantity during harvesting is high, and the haemophilus paragallinarum B strain fermentation medium is suitable for large-scale application and has a wide prospect.
Owner:山东滨州沃华生物工程有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products